Alimera Sciences Inc
ALIMDelisted Sep 16, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001267602
Alimera Sciences Inc was delisted on Sep 16, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 52 institutions reported holding it in 13F filings for Q2 2024, worth $257.9M in total; no superinvestor held it.
Holders of 5% or more of ALIM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Alimera Sciences Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Alimera Sciences Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
38 Schedule 13D and 13G filings on Alimera Sciences Inc, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2024 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 7, 2024 | Boothbay Fund Management, LLC | 13G/AOld format | – | – | – | SEC |
| Sep 18, 2024 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Sep 16, 2024 | Velan Capital Investment Management LP | 13D/AOld format | – | – | – | SEC |
| Jun 24, 2024 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| May 16, 2024 | Velan Capital Investment Management LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Lytton Laurence W | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Altium Capital Management LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Boothbay Fund Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | HBM Healthcare Investments (Cayman) Ltd. | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Stonepine Capital Management, LLC | 13G/AOld format | – | – | – | SEC |
| Dec 8, 2023 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Aug 23, 2023 | Altium Capital Management LP | 13GOld format | – | New | – | SEC |
| Aug 16, 2023 | Velan Capital Investment Management LP | 13D/AOld format | – | – | – | SEC |
| Aug 14, 2023 | Lytton Laurence W | 13GOld format | – | New | – | SEC |
| Aug 10, 2023 | Boothbay Fund Management, LLC | 13GOld format | – | New | – | SEC |
| Aug 10, 2023 | Stonepine Capital Management, LLC | 13GOld format | – | New | – | SEC |
| Aug 3, 2023 | Velan Capital Investment Management LP | 13D/AOld format | – | – | – | SEC |
| Aug 3, 2023 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| May 19, 2023 | Velan Capital Investment Management LP | 13D/AOld format | – | – | – | SEC |
| May 18, 2023 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Apr 3, 2023 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Mar 31, 2023 | Velan Capital Investment Management LP | 13DOld format | – | New | – | SEC |
| Mar 28, 2023 | Caligan Partners LP | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 8, 2023 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Oct 27, 2022 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| May 25, 2022 | Caligan Partners LP | 13DOld format | – | New | – | SEC |
| Mar 10, 2022 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Feb 3, 2022 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Apr 30, 2021 | Ocumension Therapeutics | 13GOld format | – | New | – | SEC |
| Feb 16, 2021 | Palo Alto Investors LP | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Flynn James E | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Hirschman Orin | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Alimera Sciences Inc shares.
No Form 144 notices for Alimera Sciences Inc are on file.